Israeli biotech SynVaccine is developing safe synthetic vaccines from the recipient’s own tissue cells, which the body’s immune system can easily recognize and build protection. In addition, SynVaccine’s computer-engineered vaccines cannot release the original virus. Treatment to stop pain. Israel’s Teva has begun a Phase 2b trial of TV-45070 in patients with post-herpetic neuralgia (PHN). TV-45070 inhibits the sodium channels expressed in the pain-sensing peripheral nervous system and can treat patients with various pain indications, including neuropathic and osteo-arthritis pain.
No comments:
Post a Comment